SingHealth Foundation – National Health Innovation Centre

Joint MedTech Grant Call 2016

 

Closing date: 4 July 2016 (Monday), 5 pm

Background

Medical technology development is identified as a new research growth area for SingHealth – the advancement of which is a mission spearheaded by the SingHealth Medical Technology Office (MTO), a strategic program under the SingHealth Office of Research (OoR). One of MTO’s key roles is to link researchers and their validated clinical problem with technological solutions – with an end goal of improving patient care through clinically relevant technology.

The SingHealth Foundation-National Health Innovation Centre (SHF-NHIC) Joint MedTech Grant Call 2016 is jointly supported by SingHealth Foundation (SHF) and National Health Innovation Centre (NHIC) – to fund feasibility studies and deserving pilot projects prior to embarking on the NHIC applications.

This grant aims to provide seed funding for investigators to explore novel research ideas, support exploratory efforts for early-stage projects that involve an unmet clinical need and show potential for further development with the next stage of POC funding.

The LOI application phase is intended to identify and shortlist promising project teams for invitation to the Full proposal round. Full proposals will be evaluated at the 2nd stage, by a platform-specific MedTech Review Panel.

Eligibility
  • Investigators/researchers primarily employed in SingHealth and her member institutions are encouraged to apply provided the following criteria are fulfilled:
    • Principal Investigators (PIs) with previous MedTech research funding (irrespective of funding source) of <S$1 million in total between the period 1 June 2014 to 1 June 2016 are eligible to apply.
    • PIs (other than Allied Health professionals and Nurses) must not have held more than 1 SHF grant since 2004; Allied Health professionals and Nurses must not have held more than 2 SHF grants since 2004 (i.e., a maximum of 2 SHF grants may be awarded to any PI who is not an Allied Health professional or Nurse; or 3 SHF grants if the PI is an Allied Health professional or Nurse).
    • The proposed research project must be conducted within SingHealth and the Principal Investigator (PI) must be primarily employed by SingHealth or her member institutions (e.g. MOHH employed medical officers and residents are not eligible). The PI must have an official employment (permanent/contract) throughout the effective grant period.
    • PIs must not be recipients of NMRC Transition Award (TA), NMRC Clinician Scientist Award (CSA), SingHealth Research Strategic Hire or Research Talent schemes at the point of application and upon award.
    • The project’s aims and objectives, and/or the same protocol must not be funded by other funding agencies.
  • Each eligible applicant can only submit one application per SHF/ SHF-affiliated grant call as the PI in 2016 (e.g. SHF Research Grant Call and SHF-NHIC Joint MedTech Grant Call).
  • If eligible, successful (awarded) investigators must apply for the NHIC Innovation to Develop (I2D) Grant (S$250,000) as their first follow-on funding at the end of the project, at the recommendation of NHIC. Awarded projects in this grant call may bypass the pre-proposal applications and directly submit full proposals for evaluation upon successful completion of awarded project.
  • All awarded investigators will need to agree to having a mentor for this project, assigned by MTO and mutually agreed on by the PI.
  • Applications that do not fulfil the eligibility criteria will be automatically disqualified from the Review Panel’s review.
Funding Quantum and Deliverables

The award value is capped at S$100,000 per successful application, to be utilized over a period of 1 year.

The end deliverable should be a physical clinical device, drug or diagnostic solution, potentially applicable in SingHealth and optimally, across other healthcare institutions; and/or show potential for patent protection.

Projects should aim towards securing follow-on National MedTech funding (e.g. NHIC, Singapore-MIT Alliance for Research and Technology [SMART] or Biomedical Engineering Programme [BEP] grant funding), a licensing exit or adoption by the healthcare system.

Selection Process / Criteria
  • The selection process consists of two stages: (1) LOI application, which is open to all who fit the eligibility criteria; (2) Full proposal, which is by invitation only.
  • LOI applications will be triaged for eligibility by the SingHealth OoR.
  • Each submission will be reviewed by the SingHealth MTO.
  • All proposals will be evaluated based on the following criteria:
    • Clarity of key aspects of the unmet clinical need.
    • The significance and clinical impact of the unmet need.
    • The novelty and competitiveness of the solution (if one is proposed) or clarity of the features required of a successful solution (if none is proposed yet).
    • The potential for securing National MedTech funding (e.g. NHIC I2D as a first choice, Singapore-MIT Alliance for Research and Technology [SMART] or Biomedical Engineering Programme [BEP] grant funding), a licensing exit or adoption by the healthcare system.
    • Proposals without a clear hypothesis or primarily for setting up databases and registries will not be funded.
    • The end deliverable should be a physical clinical device, drug or diagnostic solution, potentially applicable in SingHealth and optimally, across other healthcare institutions; and/or show potential for patent protection.
Submission / Application procedure
  • The completed LOI application form and all accompanying documents – ONE original endorsed hard copy and TWO soft copies (containing all information e.g. LOI, CVs in a single file [1 in word format without signatures and 1 in PDF format with signatures]), through the Host Institution Research Office to SingHealth OoR.
  • Interested applicants, please refer to SHF-NHIC Joint MedTech Grant Call – LOI Application Guidelines FINAL & SHF-NHIC Joint MedTech Grant Call – LOI Application Form FINAL for application.
  • Please refer to the list of Fundable and Non-Fundable Items in the application form when doing the budgeting.
  • Incomplete or late applications will automatically be disqualified from the Review Panel’s review.
  • Shortlisted applicant(s) will be notified of the outcomes of the LOI stage by 18 July 2016 to submit a full research proposal for review by the grant review panel. They will be required to work with the SingHealth MTO for assistance in technology matching (if needed) and proposal refinement in line with the objectives of the grant.
Contact Person

Please contact your Host Institution’s Research Office, or SingHealth Office of Research

Ms Iris Soh (Tel: 6576 7014)  E-mail: iris.soh.s.j@singhealth.com.sg

Ms Tan Yi Mei (Tel: 6576 7013)  E-mail: tan.yi.mei@singhealth.com.sg